Douglas Roblin to Hepatitis C Antibodies
This is a "connection" page, showing publications Douglas Roblin has written about Hepatitis C Antibodies.
Connection Strength
0.200
-
The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings. Ann Intern Med. 2012 Feb 21; 156(4):263-70.
Score: 0.103
-
HCV screening practices and prevalence in an MCO, 2000-2007. Am J Manag Care. 2011; 17(8):548-55.
Score: 0.097